Alzheimer Disease and Oxidative Stress - Wikidata - awgldk - TriplyDB

Alzheimer Disease and Oxidative Stress

Alzheimer Disease and Oxidative Stress

http://www.wikidata.org/entity/Q24801475

about

May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease?Cobalamin deficiency, hyperhomocysteinemia, and dementia Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder Metals and amyloid-beta in Alzheimer's disease Caffeoylquinic Acids Generated In Vitro in a High-Anthocyanin-Accumulating Sweet potato Cell Line.A Potential Alternative against Neurodegenerative Diseases: Phytodrugs Vitamin D and Alzheimer's Disease: Neurocognition to Therapeutics Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline Microglial cell dysregulation in brain aging and neurodegeneration Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases Epidemiology of Alzheimer disease Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease.Vitamin E, Turmeric and Saffron in Treatment of Alzheimer's Disease P2Y2 nucleotide receptor-mediated responses in brain cells.In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease Multiple C2 domains transmembrane protein 1 is expressed in CNS neurons and possibly regulates cellular vesicle retrieval and oxidative stress.Inactivation of the SMN complex by oxidative stress Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases.Native and synthetic ferritins for nanobiomedical applications: recent advances and new perspectives.Differential network analyses of Alzheimer's disease identify early events in Alzheimer's disease pathology Intracellular iron transport and storage: from molecular mechanisms to health implications.Alzheimer's proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer's disease.Monascus-fermented dioscorea enhances oxidative stress resistance via DAF-16/FOXO in Caenorhabditis elegans.A comparative evaluation of treatments with 17β-estradiol and its brain-selective prodrug in a double-transgenic mouse model of Alzheimer's disease Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease.Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model.Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases.Noradrenergic dysfunction in Alzheimer's disease.Phenotypic profiles and functional genomics in Alzheimer's disease and in dementia with a vascular component.Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia.Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.Metal homeostasis in Alzheimer's disease.Distinctive Pattern of Serum Elements During the Progression of Alzheimer's Disease.Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection.Effect of smoking and time on cognitive function in the elderly without dementia Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice.Commonalities in the genetics of Alzheimer's disease and Parkinson's disease.Imaging hydrogen peroxide in Alzheimer's disease via cascade signal amplification

P2860

Q24600533-6DBB4587-BB3F-4939-898A-2B17186B93BE Q24609123-813875CD-E8E8-4738-A825-6323A300C238 Q24626017-CA616BBF-5E98-46D9-8EE4-030FA655B52C Q24643555-16D257C9-DD2E-4CB6-9623-CC4F74D17742 Q24805022-A5A0F547-28F9-4ECC-81C8-438BFEB4FD6D Q26765784-E73D6490-0675-4397-814A-B07E0C3D27CB Q26782403-AD8B5340-DE76-4EF4-BEAC-1F7F29E6858E Q26784170-7CEE4FEF-7C73-4537-9D8F-CF249D7BDD5B Q26800212-DD95B095-2131-4F7D-AD1E-B2F5FD2899B6 Q26859141-C8C2392C-E084-4D0F-B092-5DE0E1174506 Q26865371-4D84A9A4-F92A-47D5-882A-9E028EC6A6CA Q27311810-5D972506-AF04-4060-92CA-1EF1D9D182D8 Q28080306-0F929226-6443-42E8-AF7F-8D26BFF6148B Q30156903-F49A6C4F-62CB-4212-8BC9-851AD1D0C9A3 Q30701725-D2D8E463-B090-44BE-A2FA-76F1D759A4AC Q33288843-54CB0BCE-FBD1-425B-93DA-C07C0A83DB9D Q33355418-30046D13-8060-4781-B131-7C495F0FD9CC Q33707944-ED188C9C-05BC-4DBA-93D3-D074BA03F5AE Q33852368-1A77FEEF-242F-429F-876F-798C090B74D5 Q34043551-701AE8B7-E154-4412-A4AD-3FA7BE9ABA70 Q34100135-DEBD615A-3928-420B-A151-C7B05EC06C60 Q34127614-202DCDF3-C549-4884-B627-AD6F84BF3D28 Q34321472-378408AD-2799-4608-AC0C-2A3FC1EC39F7 Q34527792-CF796BE5-CDDB-45EB-8FA2-EDF7F8ABF8C1 Q34575780-423EF0AB-0191-43A3-AB24-15DDBB1B2624 Q35573492-3307BBFE-2931-4FBA-BE22-400EF3837EDD Q35600801-0B9AE64F-EA6E-4208-ADB7-6D07689AE163 Q35749478-A7A3C840-F171-4F18-B319-7650CA8C669D Q35841700-AB706806-EF81-487D-B0B4-E98C1014A087 Q35976397-3B5B38DB-EC58-4FDC-B333-4380B862C773 Q36076365-A56425B9-A506-4F61-926F-EE3C2FF04249 Q36492356-E0FC34EF-98B8-4FE7-BBE3-7BC2A1277616 Q36666749-F4FD0AB0-D91F-4934-8706-29C1674B5818 Q36972735-9B775C34-EA91-4CC0-915C-ACEAB93F511D Q37160197-CB38FFCF-A69E-4EB5-8AC4-F0DF24094034 Q37174350-590B2A9D-F776-49E3-9B86-734AA90647CB Q37216153-E6928B0C-D7D7-4FBE-A4E9-F4FE70DB6B08 Q37295234-7C1B631C-C77D-4DEA-9FA1-A4D606FC5F1A Q37352061-33AAC131-FA34-4D02-9B47-1B45FEFE6C68 Q37352823-02C5A3F0-1EB2-4163-A37D-CFA3C150C482

P2860

Alzheimer Disease and Oxidative Stress

http://www.wikidata.org/entity/Q24801475

description

2002 nî lūn-bûn

@nan

2002 թուականին հրատարակուած գիտական յօդուած

@hyw

2002 թվականին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Alzheimer Disease and Oxidative Stress

@ast

Alzheimer Disease and Oxidative Stress

@en

Alzheimer Disease and Oxidative Stress

@nl

type

label

Alzheimer Disease and Oxidative Stress

@ast

Alzheimer Disease and Oxidative Stress

@en

Alzheimer Disease and Oxidative Stress

@nl

prefLabel

Alzheimer Disease and Oxidative Stress

@ast

Alzheimer Disease and Oxidative Stress

@en

Alzheimer Disease and Oxidative Stress

@nl

P1433

Q24801475-3ACEF653-65A0-4BBC-84D9-8EA0355A08D8

P1476

Q24801475-67587F41-8378-4B99-978E-FE9FD3CCE0D3

P2093

Q24801475-1E900095-581B-4A7A-9EA0-C46601B0F3F8

Q24801475-68B6F6AB-11A7-4C1F-B0E6-2C8E97E2ED2A

P2860

Q24801475-16F87BFB-0762-440C-867F-03C9B4E5CD91

Q24801475-1C63CD85-EEA5-46D5-9DBE-F2D10064DD79

Q24801475-28DDB51F-CCD5-47F2-B13D-D84397469255

Q24801475-2EC3F13A-CE9F-4C7D-B35D-37F741D5C18B

Q24801475-39C20BCD-DE51-486C-9705-8EBB7E36733F

Q24801475-4DFCBA70-B772-42D4-951C-BDB0786A43AC

Q24801475-66188C06-3588-426B-A894-B66E568003AE

Q24801475-6B267BCF-FD48-470E-B85D-751A697A9C8D

Q24801475-830698D9-7A9B-4BBD-AB99-AD6CB7F670CD

Q24801475-8DD4509A-449F-4EA3-A74D-FC0429B95839

P304

Q24801475-99BC5CCE-833C-41A9-BF41-F50824DF782B

P31

Q24801475-1511E812-C719-41E2-8E6A-9CA6060409C9

P3181

Q24801475-9F96A54F-783E-41C9-B4DB-C90ECF351ED3

P356

Q24801475-014938CF-5934-4388-A390-3BC65DCFA879

P433

Q24801475-32450F9F-CF47-48DE-85F4-D820382E8669

P478

Q24801475-7D3CF0CD-4A37-4E1B-80B5-379ADA4A3C12

P50

Q24801475-22CF29FB-445F-4B3B-9082-1314B12C0458

P577

Q24801475-736AD829-FCFC-4A12-B946-8C152DB7CE78

P698

Q24801475-3204EF2B-632E-4450-A7D1-5BD131A34A7E

P921

Q24801475-CBA22A5C-5985-4B97-81C0-C9CC5BE4BCF0

P932

Q24801475-390C066D-F615-40EC-8A6A-977B51C200D5

P3181

P356

S1110724302203010

P1433

Journal of Biomedicine and Biotechnology

P1476

Alzheimer Disease and Oxidative Stress

@en

P2093

Adam D. Cash

http://www.w3.org/2001/XMLSchema#string

Mark A. Smith

http://www.w3.org/2001/XMLSchema#string

P2860

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures

Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Radical AGEing in Alzheimer's disease.

Progressive hyperphosphorylation of neurofilament heavy subunits with aging: possible involvement in the mechanism of neurofilament accumulation.

Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.

RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.

P304

120-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2892474

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/S1110724302203010

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12488575

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

161361

http://www.w3.org/2001/XMLSchema#string